The fully linked HTML version of this article has now been published.
Development ePress online publication date 3 Sep 2003
doi: 10.1242/dev.00715
Research article: Development and disease
Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of Stat5
Weiwen Long,
Kay-Uwe Wagner,
K. C. Kent Lloyd,
Nadine Binart,
Jonathan M. Shillingford,
Lothar Hennighausen,
and
Frank E. Jones*
* Author for correspondence (e-mail: fjones{at}tulane.edu)
The ERBB family of type 1 receptor tyrosine kinases and their ligands have crucial functions during mammopoiesis, but the signaling networks that ultimately regulate ERBB activity in the breast have remained elusive. Here, we show that mice with Cre-lox mediated deletions of both Erbb4 alleles within the developing mammary gland (Erbb4Flox/FloxWap-Cre) fail to accumulate lobuloalveoli or successfully engage lactation at parturition owing, in part, to impaired epithelial proliferation. Analysis of the mammary differentiation factor STAT5 by immunohistochemistry and western blot revealed a complete ablation of STAT5 activation in Erbb4Flox/FloxWap-Cre mammary epithelium at parturition. Consistent with disrupted STAT5 function, Erbb4Flox/FloxWap-Cre mammary glands at parturition failed to express the mammary epithelial differentiation marker NPT2B. Defects in epithelial functional differentiation at parturition were accompanied by a profound reduction in expression of the STAT5-regulated milk genes casein beta and whey acidic protein. We propose that ERBB4 functions as an essential mediator of STAT5 signaling, and that loss of STAT5 activity contributes to the impaired functional differentiation of mammary glands observed in mice containing conditional Erbb4 deletions.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. D. Thor, S. M. Edgerton, and F. E. Jones
Subcellular Localization of the HER4 Intracellular Domain, 4ICD, Identifies Distinct Prognostic Outcomes for Breast Cancer Patients
Am. J. Pathol.,
November 1, 2009;
175(5):
1802 - 1809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Muraoka-Cook, M. A. Sandahl, K. E. Strunk, L. C. Miraglia, C. Husted, D. M. Hunter, K. Elenius, L. A. Chodosh, and H. S. Earp III
ErbB4 Splice Variants Cyt1 and Cyt2 Differ by 16 Amino Acids and Exert Opposing Effects on the Mammary Epithelium In Vivo
Mol. Cell. Biol.,
September 15, 2009;
29(18):
4935 - 4948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Barros, B. Calabrese, P. Chamero, A. J. Roberts, E. Korzus, K. Lloyd, L. Stowers, M. Mayford, S. Halpain, and U. Muller
Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system
PNAS,
March 17, 2009;
106(11):
4507 - 4512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Muraoka-Cook, M. Sandahl, D. Hunter, L. Miraglia, and H. S. Earp III
Prolactin and ErbB4/HER4 Signaling Interact via Janus Kinase 2 to Induce Mammary Epithelial Cell Gene Expression Differentiation
Mol. Endocrinol.,
October 1, 2008;
22(10):
2307 - 2321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Naresh, A. D. Thor, S. M. Edgerton, K. C. Torkko, R. Kumar, and F. E. Jones
The HER4/4ICD Estrogen Receptor Coactivator and BH3-Only Protein Is an Effector of Tamoxifen-Induced Apoptosis
Cancer Res.,
August 1, 2008;
68(15):
6387 - 6395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-P. Chuu, R.-Y. Chen, J. L. Barkinge, M. F. Ciaccio, and R. B. Jones
Systems-Level Analysis of ErbB4 Signaling in Breast Cancer: A Laboratory to Clinical Perspective
Mol. Cancer Res.,
June 1, 2008;
6(6):
885 - 891.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Hennighausen and G. W. Robinson
Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B
Genes & Dev.,
March 15, 2008;
22(6):
711 - 721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-M. Feng, C. I. Sartor, D. Hunter, H. Zhou, X. Yang, L. S. Caskey, R. Dy, R. S. Muraoka-Cook, and H. S. Earp III
The HER4 Cytoplasmic Domain, But Not Its C Terminus, Inhibits Mammary Cell Proliferation
Mol. Endocrinol.,
August 1, 2007;
21(8):
1861 - 1876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Strunk, C. Husted, L. C. Miraglia, M. Sandahl, W. A. Rearick, D. M. Hunter, H. S. Earp III, and R. S. Muraoka-Cook
HER4 D-Box Sequences Regulate Mitotic Progression and Degradation of the Nuclear HER4 Cleavage Product s80HER4
Cancer Res.,
July 15, 2007;
67(14):
6582 - 6590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kirkegaard, L. M. McGlynn, F. M. Campbell, S. Muller, S. M. Tovey, B. Dunne, K. V. Nielsen, T. G. Cooke, and J. M.S. Bartlett
Amplified in Breast Cancer 1 in Human Epidermal Growth Factor Receptor-Positive Tumors of Tamoxifen-Treated Breast Cancer Patients
Clin. Cancer Res.,
March 1, 2007;
13(5):
1405 - 1411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Muraoka-Cook, L. S. Caskey, M. A. Sandahl, D. M. Hunter, C. Husted, K. E. Strunk, C. I. Sartor, W. A. Rearick Jr., W. McCall, M. K. Sgagias, et al.
Heregulin-Dependent Delay in Mitotic Progression Requires HER4 and BRCA1.
Mol. Cell. Biol.,
September 1, 2006;
26(17):
6412 - 6424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Linggi and G. Carpenter
ErbB-4 s80 Intracellular Domain Abrogates ETO2-dependent Transcriptional Repression
J. Biol. Chem.,
September 1, 2006;
281(35):
25373 - 25380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Muraoka-Cook, M. Sandahl, C. Husted, D. Hunter, L. Miraglia, S.-m. Feng, K. Elenius, and H. S. Earp III
The Intracellular Domain of ErbB4 Induces Differentiation of Mammary Epithelial Cells
Mol. Biol. Cell,
September 1, 2006;
17(9):
4118 - 4129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhu, L. L. Sullivan, S. S. Nair, C. C. Williams, A. K. Pandey, L. Marrero, R. K. Vadlamudi, and F. E. Jones
Coregulation of Estrogen Receptor by ERBB4/HER4 Establishes a Growth-Promoting Autocrine Signal in Breast Tumor Cells
Cancer Res.,
August 15, 2006;
66(16):
7991 - 7998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Naresh, W. Long, G. A. Vidal, W. C. Wimley, L. Marrero, C. I. Sartor, S. Tovey, T. G. Cooke, J. M.S. Bartlett, and F. E. Jones
The ERBB4/HER4 Intracellular Domain 4ICD Is a BH3-Only Protein Promoting Apoptosis of Breast Cancer Cells.
Cancer Res.,
June 15, 2006;
66(12):
6412 - 6420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Arasada and G. Carpenter
Secretase-dependent Tyrosine Phosphorylation of Mdm2 by the ErbB-4 Intracellular Domain Fragment
J. Biol. Chem.,
September 2, 2005;
280(35):
30783 - 30787.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Howard, H. Panchal, A. McCarthy, and A. Ashworth
Identification of the scaramanga gene implicates Neuregulin3 in mammary gland specification
Genes & Dev.,
September 1, 2005;
19(17):
2078 - 2090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Escher, E. Lacazette, M. Courtet, A. Blindenbacher, L. Landmann, G. Bezakova, K. C. Lloyd, U. Mueller, and H. R. Brenner
Synapses Form in Skeletal Muscles Lacking Neuregulin Receptors
Science,
June 24, 2005;
308(5730):
1920 - 1923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Clark, C. C. Williams, T. T. Duplessis, K. L. Moring, A. R. Notwick, W. Long, W. S. Lane, I. Beuvink, N. E. Hynes, and F. E. Jones
ERBB4/HER4 Potentiates STAT5A Transcriptional Activity by Regulating Novel STAT5A Serine Phosphorylation Events
J. Biol. Chem.,
June 24, 2005;
280(25):
24175 - 24180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Vidal, A. Naresh, L. Marrero, and F. E. Jones
Presenilin-dependent {gamma}-Secretase Processing Regulates Multiple ERBB4/HER4 Activities
J. Biol. Chem.,
May 20, 2005;
280(20):
19777 - 19783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Williams, J. G. Allison, G. A. Vidal, M. E. Burow, B. S. Beckman, L. Marrero, and F. E. Jones
The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone
J. Cell Biol.,
November 8, 2004;
167(3):
469 - 478.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2003